Document Type : Short Communication
Authors
- Mahmood Barati 1
- Mazaher Gholipourmalekabadi 2
- Javad Ranjbari 3
- Pegah Shakib 4
- Mohammad Ali Bahar 5
- Ali Samadikuchaksaraei 1
1 Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
3 Department of Biotechnology, Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
5 Department of Immunology and Burn Research Center, Iran University of Medical Sciences, Tehran, Iran
Abstract
Background: Pseudomonas aeruginosa infection is one of the major challenges in burn patients. This organism is resistant to a wide range of antibiotics. The aim of this study was to investigate the antibiotic susceptibility and genetic relatedness in Pseudomonas aeruginosa isolated from patients admitted to Motahari Burn Center, Tehran, Iran.
Methods: This study was conducted on 186 burn patients with Pseudomonas aeruginosa colonization following admission in Motahari Burn Center during one year. Antibiotic resistance test was performed by disc diffusion method and genetic relatedness was evaluated by PCR-RAPD analysis.
Results: The highest and lowest percentage of resistance was observed against ceftizoxime and ciprofloxacin. The genotyping study by RAPD PCR technique revealed 57 different genotypes, among which RAPD 5, RAPD 8, and RAPD 9 were the most prevalent patterns and produced by 14%, 9%, and 7% of the isolates, respectively.
Conclusion: In total, no association was found between RAPD genotypes and antibiotic resistance patterns, and death rate.
Keywords
- Association AB. Burn incidence and treatment in the US: 2000 fact sheet. Chicago, IL: ABA. 2007.
- Rezaei E, Safari H, Naderinasab M, Aliakbarian H. Common pathogens in burn wound and changes in their drug sensitivity. Burns 2011; 37(5):805-7. doi: 10.1016/j.burns.2011.01.019.
- Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41(3):1192-202. doi: 10.1128/JCM.41.3.1192-1202.2003.
- Pruitt Jr BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998; 22(2):135-45. doi: 10.1007/s002689900361.
- Azzopardi EA, Azzopardi E, Camilleri L, Villapalos J, Boyce DE, Dziewulski P, et al. Gram negative wound infection in hospitalised adult burn patients-systematic review and metanalysis. PloS One 2014; 9(4):e95042. doi: 10.1371/journal.pone.0095042.
- Japoni A, Alborzi A, Kalani M, Nasiri J, Hayati M, Farshad S. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. Burns 2006; 32(3):343-7. doi: 10.1016/j.burns.2005.10.017.
- Shahcheraghi F, Feizabadi MM, Yamin V, Abiri R, Abedian Z. Serovar determination, drug resistance patterns and plasmid profiles of Pseudomonas aeruginosa isolated from burn patients at two hospitals of Tehran (IRAN). Burns 2003; 29(6):547-51. doi: 10.1016/s0305-4179(03)00142-6.
- Aujoulat F, Lebreton F, Romano S, Delage M, Marchandin H, Brabet M, et al. Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care. Ann Clin Microbiol Antimicrob 2011; 10:27. doi: 10.1186/1476-0711-10-27.
- Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14(2):403-11. doi: 10.1093/clinids/14.2.403.
- Estahbanati HK, Kashani PP, Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 2002; 28(4):340-8. doi: 10.1016/s0305-4179(02)00024-4.
- Renders N, Römling Y, Verbrugh H, van Belkum A. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 1996; 34(12):3190-5. doi: 10.1128/jcm.34.12.3190-3195.1996.
- Nanvazadeh F, Khosravi AD, Zolfaghari MR, Parhizgari N. Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR. Burns 2013; 39(7):1409-13. doi: 10.1016/j.burns.2013.03.008.
- Douglas MW, Mulholland K, Denyer V, Gottlieb T. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study. Burns 2001; 27(2):131-5. doi: 10.1016/s0305-4179(00)00084-x.
- Yu Z, Huang M. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients in the ICU. Zhongguo Weishengtaxixue Zazhi/Chinese Journal of Microecology 2009; 21(3):264-6.
- Trautmann M, Bauer C, Schumann C, Hahn P, Höher M, Haller M, et al. Common RAPD pattern of Pseudomonas aeruginosa from patients and tap water in a medical intensive care unit. Int J Hyg Environ Health 2006; 209(4):325-31. doi: 10.1016/j.ijheh.2006.04.001.
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scotts Diagnostic Microbiology. 11th ed. US: Mosby; 2002.
- Hsueh PR, Ko WC, Wu JJ, Lu JJ, Wang FD, Wu HY, et al. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan. J Microbiol Immunol Infect 2010; 43(5):452-5. doi: 10.1016/S1684-1182(10)60070-9.
- Hernández J, Ferrús MA, Hernández M, Owen RJ. Arbitrary primed PCR fingerprinting and serotyping of clinical Pseudomonas aeruginosa strains. FEMS Immunol Med Microbiol 1997; 17(1):37-47. doi: 10.1111/j.1574-695X.1997.tb00994.x.
- Kaskatepe B, Kiymaci ME, Suzuk S, Erdem SA, Cesur S, Yildiz S. Antibacterial effects of cinnamon oil against carbapenem resistant nosocomial Acinetobacter baumannii and Pseudomonas aeruginosa isolates. Industrial Crops and Products 2016; 81:191-4. doi: 10.1016/j.indcrop.2015.11.058.
- Sader HS, Castanheira M, Shortridge D, Mendes RE, Flamm RK. Antimicrobial activity of ceftazidime-avibactam tested against multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa isolates from US medical centers, 2013 to 2016. Antimicrob Agents Chemother 2017; 61(11):e01045-17. doi: 10.1128/AAC.01045-17.
- Abbassi Ghaleh Sorkh M, Shokoohizadeh L, Rashidi N, Tajbakhsh E. Molecular analysis of Pseudomonas aeruginosa strains isolated from burn patients by repetitive extragenic palindromic-PCR (rep-PCR). Iran Red Crescent Med J 2017; 19(4):e43508.
- Cillóniz C, Gabarrús A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, et al. community-acquired pneumonia due to multidrug-and non–multidrug-resistant pseudomonas aeruginosa. Chest 2016; 150(2):415-25. doi: 10.1016/j.chest.2016.03.042.
- Khosravi AD, Hoveizavi H, Mohammadian A, Farahani A, Jenabi A. Genotyping of multidrug-resistant strains of Pseudomonas aeruginosa isolated from burn and wound infections by ERIC-PCR. Acta Cir Bras 2016; 31(3):206-11. doi: 10.1590/S0102-865020160030000009.
- Saderi H, Owlia P. Detection of multidrug resistant (MDR) and extremely drug resistant (XDR) P. aeruginosa isolated from patients in Tehran, Iran. Iran J Pathol 2015; 10(4):265-71.
- Radan M, Moniri R, Khorshidi A, Gilasi H, Norouzi Z, Beigi F, et al. Emerging carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP among burn patients in Isfahan, Iran. Arch Trauma Res 2016; 5(3):e33664. doi: 10.5812/atr.33664.
- Karimi H, Montevalian A, Motabar AR, Safari R, Parvas MS, Vasigh M. Epidemiology of paediatric burns in Iran. Ann Burns Fire Disasters 2012; 25(3):115-20.
- Azimi L, Motevallian A, Ebrahimzadeh Namvar A, Asghari B, Lari AR. Nosocomial infections in burned patients in motahari hospital, tehran, iran. Dermatol Res Pract 2011; 2011:436952. doi: 10.1155/2011/436952.
- Bahar MA, Pakyari M, Bahar R. Burns in Tehran: demographic, etiological, and clinical trends. Asian Biomedicine 2017; 8(2):241-5. doi: 10.5372/1905-7415.0802.285.
- Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns 2008; 34(8):1103-7. doi: 10.1016/j.burns.2008.02.010.
- Nazik H, Ongen B, Erturan Z, Salcioglu M. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Jpn J Infect Dis 2007; 60(2-3):82-6.
- Deschaght P, Van Simaey L, Decat E, Van Mechelen E, Brisse S, Vaneechoutte M. Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD). Res Microbiol 2011; 162(4):386-92. doi: 10.1016/j.resmic.2011.02.002.
)